Germany's federal research ministry coordinating national funding alignment with European research priorities across health, quantum, food, and materials ERA-NETs.
Germany's federal research ministry (commonly known as BMBF) that funds and coordinates national research programmes. Within H2020, their primary role is aligning German national funding with European research priorities through ERA-NET Cofund actions — pooling national budgets with EU co-funding to launch joint transnational research calls. They participated in 22 ERA-NET Cofunds across health, materials, food, quantum technologies, and environment, making them one of the most active national funding bodies in Horizon 2020. Their involvement signals which research domains Germany considers strategically important at the federal level.
Eight ERA-NETs in health — E-Rare-3 (rare diseases), TRANSCAN-2/3 (cancer), ERA-CVD (cardiovascular), ERACoSysMed (systems medicine), NEURON Cofund (brain diseases), ERA PerMed (personalised medicine), JPIAMR-ACTION (antimicrobial resistance).
QuantERA (EUR 1.6M) and QuantERA II (EUR 1.7M, their largest single grant) covering quantum communication, computing, simulation, and sensing.
FACCE SURPLUS (sustainable agriculture), SUSFOOD2 (food production/consumption), SusCrop (crop production), and ICT-AGRI-FOOD (smart agri-food systems).
M-ERA.NET 2 and M-ERA.NET3 (materials research, batteries, circular economy), plus EuroNanoMed III (nanomedicine materials applications).
JPI-EC-AMR, EXEDRA (expanding JPIAMR), and JPIAMR-ACTION — a sustained investment across three successive projects from 2015 to 2025.
ASM2 (Second Arctic Science Ministerial) — their only coordinated project, a high-level policy initiative on Arctic climate research.
In 2014–2018, BMFTR focused heavily on biomedical ERA-NETs — rare diseases, cardiovascular research, systems medicine, and neuroscience dominated their portfolio, alongside early materials and photonics programmes. From 2019 onward, the focus broadened significantly: quantum technologies received their largest grants (QuantERA II), sustainability and Green Deal themes became prominent (M-ERA.NET3 references SDGs and circular economy), and food system digitisation (ICT-AGRI-FOOD) appeared. The health portfolio also matured from disease-specific funding toward cross-cutting themes like antimicrobial resistance transmission and cancer prevention policy.
Germany's federal research ministry is shifting funding coordination toward quantum technologies, green materials, and food-system sustainability — expect future calls in these domains.
BMFTR operates almost exclusively as a participant (26 of 27 projects), which is typical for a national funding ministry — they contribute national budget commitments and policy alignment rather than scientific leadership. With 168 unique partners across 43 countries, they are a major network hub connecting funding agencies across Europe and beyond. Working with them means accessing Germany's national research funding infrastructure and their ability to co-fund transnational research calls.
One of the most broadly connected funding bodies in H2020, with 168 consortium partners spanning 43 countries — reflecting their role in nearly every major ERA-NET Cofund. Their network is genuinely global, extending well beyond the EU to include associated countries and international cooperation partners.
As Germany's federal research ministry, BMFTR brings something no university or research institute can: the authority and budget to align national funding programmes with European priorities. Their participation in an ERA-NET signals that Germany will co-fund transnational calls in that domain, making them a critical enabler for any consortium seeking to launch joint calls. For researchers and funding agencies alike, having BMFTR in a consortium means access to one of Europe's largest national R&D budgets.
